Literature DB >> 7492313

The activity of calmodulin is altered by phosphorylation: modulation of calmodulin function by the site of phosphate incorporation.

D B Sacks1, B Mazus, J L Joyal.   

Abstract

Calmodulin transduces Ca2+ signals by binding to and activating essential regulatory enzymes. The large number of intracellular targets for calmodulin raises the possibility that mechanisms in addition to Ca2+ may modulate calmodulin activity. Phosphocalmodulin is found in cells and tissues, and calmodulin phosphorylation is enhanced by several mitogens. Phosphorylation of calmodulin on serine/threonine residues by casein kinase II decreased its ability to activate Ca2+/calmodulin-dependent protein kinase II (CaM-kinase II). The major effect was a 2.5-fold increase in the concentration at which half-maximal velocity (K0.5) was attained, with no apparent alteration in the Vmax, or the K0.5 for Ca2+. In contrast, calmodulin phosphorylated on tyrosine residues by the insulin receptor kinase produced an increase in the Vmax, with no alteration in the affinity for CaM-kinase II or the K0.5 for Ca2+. Direct determination by surface plasmon resonance of the dissociation constants with a synthetic peptide corresponding to the calmodulin-binding domain of CaM-kinase II revealed that phosphorylation on serine/threonine residues of calmodulin significantly decreased its affinity for the peptide, while tyrosine phosphorylation had no effect on binding. In contrast to CaM-kinase II, neither serine/threonine nor tyrosine phosphorylation of calmodulin altered its ability to activate calcineurin. These data indicate that phosphorylation of calmodulin differentially modifies its interaction with individual target enzymes. Moreover, the amino acid residues phosphorylated provide an additional level of control. These results demonstrate that phosphorylation is an in vitro regulatory mechanism in the targeting of calmodulin responses and, coupled with the stoichiometric phosphorylation of calmodulin in rat hepatocytes, suggest that it may be relevant in intact cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7492313      PMCID: PMC1136245          DOI: 10.1042/bj3120197

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  53 in total

1.  Analysis of sites phosphorylated on acetyl-CoA carboxylase in response to insulin in isolated adipocytes. Comparison with sites phosphorylated by casein kinase-2 and the calmodulin-dependent multiprotein kinase.

Authors:  T A Haystead; D G Campbell; D G Hardie
Journal:  Eur J Biochem       Date:  1988-08-01

2.  Domain II of calmodulin is involved in activation of calcineurin.

Authors:  M Y Hurwitz; J A Putkey; C B Klee; A R Means
Journal:  FEBS Lett       Date:  1988-09-26       Impact factor: 4.124

3.  Mapping of calmodulin-binding domain of Ca2+/calmodulin-dependent protein kinase II from rat brain.

Authors:  R M Hanley; A R Means; B E Kemp; S Shenolikar
Journal:  Biochem Biophys Res Commun       Date:  1988-04-15       Impact factor: 3.575

Review 4.  Calcineurin.

Authors:  C B Klee; G F Draetta; M J Hubbard
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1988

5.  Calcium/calmodulin-dependent protein kinase II. Characterization of distinct calmodulin binding and inhibitory domains.

Authors:  M E Payne; Y L Fong; T Ono; R J Colbran; B E Kemp; T R Soderling; A R Means
Journal:  J Biol Chem       Date:  1988-05-25       Impact factor: 5.157

6.  Activation of casein kinase II in response to insulin and to epidermal growth factor.

Authors:  J Sommercorn; J A Mulligan; F J Lozeman; E G Krebs
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

7.  Insulin-like growth factor I and insulin rapidly increase casein kinase II activity in BALB/c 3T3 fibroblasts.

Authors:  J K Klarlund; M P Czech
Journal:  J Biol Chem       Date:  1988-11-05       Impact factor: 5.157

8.  Functional significance of the central helix in calmodulin.

Authors:  J A Putkey; T Ono; M F VanBerkum; A R Means
Journal:  J Biol Chem       Date:  1988-08-15       Impact factor: 5.157

9.  The phosphorylation of calmodulin and calmodulin fragments by kinase fractions from bovine brain.

Authors:  L A Heppel; D L Newton; C B Klee; G F Draetta
Journal:  Biochim Biophys Acta       Date:  1988-10-28

10.  Insulin stimulates the phosphorylation of calmodulin in intact adipocytes.

Authors:  J R Colca; D B DeWald; J D Pearson; B J Palazuk; J P Laurino; J M McDonald
Journal:  J Biol Chem       Date:  1987-08-25       Impact factor: 5.157

View more
  6 in total

Review 1.  Small proteins that modulate calmodulin-dependent signal transduction: effects of PEP-19, neuromodulin, and neurogranin on enzyme activation and cellular homeostasis.

Authors:  J R Slemmon; B Feng; J A Erhardt
Journal:  Mol Neurobiol       Date:  2000 Aug-Dec       Impact factor: 5.590

2.  1-[N, O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosyl]-4- phenylpiperazine (KN-62), an inhibitor of calcium-dependent camodulin protein kinase II, inhibits both insulin- and hypoxia-stimulated glucose transport in skeletal muscle.

Authors:  J T Brozinick; T H Reynolds; D Dean; G Cartee; S W Cushman
Journal:  Biochem J       Date:  1999-05-01       Impact factor: 3.857

3.  Serine/threonine phosphorylation of calmodulin modulates its interaction with the binding domains of target enzymes.

Authors:  E Leclerc; C Corti; H Schmid; S Vetter; P James; E Carafoli
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

Review 4.  Inputs and outputs of insulin receptor.

Authors:  Yipeng Du; Taotao Wei
Journal:  Protein Cell       Date:  2014-03-16       Impact factor: 14.870

5.  Melatonin stimulates dendrite formation and complexity in the hilar zone of the rat hippocampus: participation of the Ca++/Calmodulin complex.

Authors:  Aline Domínguez-Alonso; Marcela Valdés-Tovar; Héctor Solís-Chagoyán; Gloria Benítez-King
Journal:  Int J Mol Sci       Date:  2015-01-16       Impact factor: 5.923

6.  Mechanisms regulating resistance to inhibitors of topoisomerase II.

Authors:  Ram N Ganapathi; Mahrukh K Ganapathi
Journal:  Front Pharmacol       Date:  2013-08-01       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.